GeneDx Holdings News

TD Cowen Adjusts GeneDx Holdings' Price Target to $24 From $14, Keeps Buy Rating

MT NewswiresApr 30 11:22 ET

GeneDx Hldgs Analyst Ratings

BenzingaApr 30 07:42 ET

BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $19

BenzingaApr 30 07:43 ET

GeneDx Holdings (WGS) Receives a Buy From BTIG

TipRanksApr 30 06:26 ET

GeneDx Hldgs Analyst Ratings

BenzingaApr 22 13:31 ET

GeneDx Hldgs Analyst Ratings

BenzingaApr 15 10:23 ET

GeneDx Holdings (WGS) Gets a Buy From TD Cowen

TipRanksMar 28 07:15 ET

Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)

TipRanksFeb 22 05:30 ET

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), GeneDx Holdings (WGS) and Halozyme (HALO)

TipRanksFeb 21 01:11 ET

GeneDx Holdings (WGS) Gets a Buy From BTIG

TipRanksJan 2 09:55 ET

BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)

TipRanksDec 31, 2023 05:28 ET

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $6

BenzingaNov 1, 2023 09:27 ET

GeneDx Hldgs Analyst Ratings

BenzingaNov 1, 2023 09:25 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), GeneDx Holdings (WGS) and Protalix (PLX)

TipRanksOct 31, 2023 06:40 ET

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $7

BenzingaAug 9, 2023 11:47 ET

GeneDx Hldgs Analyst Ratings

BenzingaAug 9, 2023 11:47 ET

GeneDx Holdings (WGS) Receives a Buy From BTIG

TipRanksJul 28, 2023 06:05 ET

GeneDx Hldgs Analyst Ratings

BenzingaJul 24, 2023 08:13 ET

Goldman Sachs Adjusts Price Target on GeneDx to $8 From $9, Maintains Neutral Rating

MT NewswiresJul 21, 2023 11:50 ET

GeneDx Hldgs Analyst Ratings

BenzingaJul 21, 2023 08:11 ET